GitLab all set to go public as revenues – and losses – rise

IPO was expected last year but then we had a pandemic


DevOps darling GitLab has finally filed for an Initial Public Offering (IPO) as revenues continue to grow and losses widen.

The IPO had been expected in 2020 but the company put things off due to the pandemic until late last week, when the paperwork was filed with the US Securities and Exchange Commission (SEC).

The company, founded in 2014, has remained tight-lipped over the sums involved, although the filed S-1 form recorded that the proposed maximum aggregate offering price is estimated at $100m.

A spokesperson told The Register that comment could not be made due to an SEC-mandated quiet period.

GitLab has long sought to be a one-stop shop for developers, competing both with GitHub (acquired by Microsoft for a cool $7.5bn in 2018) and other DevOps pipeline companies. The business has received numerous funding rounds over the years: the latest was in 2019 when it received a $268 cash injection that valued the business at $2.75bn, which more than doubled during 2020.

In the IPO document, Gitlabs said it was on course to grow revenues to $233m in its current financial year ending in 2022. This compares to the $152.2m reported in fiscal 2021 and the $81.2m in the year before that.

However, losses also widened over those years. The net loss in fiscal 2020 was $130.7m – but it was $192.2m in fiscal 2021. Net loss reached $69m for the six months ended 31 July 2021, up from $43.5m for the same time last year.

The IPO will be of Class A common stock. The stock is identical to GitLab's Class B with the exception of voting and conversion rights. Each Class B share is worth 10 votes per share compared to Class A's one vote. Class B stock can also be converted into Class A stock.

CEO Sid Sijbrandij currently owns 25,690,901 Class B shares, or 18.9 per cent of the company, according to the filing. ®

Similar topics


Other stories you might like

  • Google sours on legacy G Suite freeloaders, demands fee or flee

    Free incarnation of online app package, which became Workplace, is going away

    Google has served eviction notices to its legacy G Suite squatters: the free service will no longer be available in four months and existing users can either pay for a Google Workspace subscription or export their data and take their not particularly valuable businesses elsewhere.

    "If you have the G Suite legacy free edition, you need to upgrade to a paid Google Workspace subscription to keep your services," the company said in a recently revised support document. "The G Suite legacy free edition will no longer be available starting May 1, 2022."

    Continue reading
  • SpaceX Starlink sat streaks now present in nearly a fifth of all astronomical images snapped by Caltech telescope

    Annoying, maybe – but totally ruining this science, maybe not

    SpaceX’s Starlink satellites appear in about a fifth of all images snapped by the Zwicky Transient Facility (ZTF), a camera attached to the Samuel Oschin Telescope in California, which is used by astronomers to study supernovae, gamma ray bursts, asteroids, and suchlike.

    A study led by Przemek Mróz, a former postdoctoral scholar at the California Institute of Technology (Caltech) and now a researcher at the University of Warsaw in Poland, analysed the current and future effects of Starlink satellites on the ZTF. The telescope and camera are housed at the Palomar Observatory, which is operated by Caltech.

    The team of astronomers found 5,301 streaks leftover from the moving satellites in images taken by the instrument between November 2019 and September 2021, according to their paper on the subject, published in the Astrophysical Journal Letters this week.

    Continue reading
  • AI tool finds hundreds of genes related to human motor neuron disease

    Breakthrough could lead to development of drugs to target illness

    A machine-learning algorithm has helped scientists find 690 human genes associated with a higher risk of developing motor neuron disease, according to research published in Cell this week.

    Neuronal cells in the central nervous system and brain break down and die in people with motor neuron disease, like amyotrophic lateral sclerosis (ALS) more commonly known as Lou Gehrig's disease, named after the baseball player who developed it. They lose control over their bodies, and as the disease progresses patients become completely paralyzed. There is currently no verified cure for ALS.

    Motor neuron disease typically affects people in old age and its causes are unknown. Johnathan Cooper-Knock, a clinical lecturer at the University of Sheffield in England and leader of Project MinE, an ambitious effort to perform whole genome sequencing of ALS, believes that understanding how genes affect cellular function could help scientists develop new drugs to treat the disease.

    Continue reading

Biting the hand that feeds IT © 1998–2022